These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 7854856)

  • 1. [Adherence of isolated Candida albicans strains from HIV+ infected patients to buccal epithelial cells: correlation with serotype, sensitivity to fluconazole and virulence].
    Imbert-Bernard C; Valentin A; Reynes J; Mallié M; Bastide JM
    Pathol Biol (Paris); 1994 Jun; 42(6):567-73. PubMed ID: 7854856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers.
    Lyon JP; de Resende MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Nov; 102(5):632-8. PubMed ID: 17052640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between fluconazole sensitivity of Candida albicans isolates from HIV positive patients and serotype, adherence and CD4+ lymphocyte count.
    Imbert-Bernard C; Valentin A; Reynes J; Mallié M; Bastide JM
    Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):711-6. PubMed ID: 7843175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic profiles and virulence attributes of Candida albicans isolates from patients with oral lichen planus.
    Zeng X; Xiong C; Wang Z; Jiang L; Hou X; Shen J; Zhou M; Chen Q
    APMIS; 2008 Apr; 116(4):284-91. PubMed ID: 18397463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence of Candida albicans strains isolated from AIDS patients. Comparison with pathogenic yeasts isolated from patients without HIV infection.
    Pereiro M; Losada A; Toribio J
    Br J Dermatol; 1997 Jul; 137(1):76-80. PubMed ID: 9274628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Candida albicans: the relationship between morphotypes and in-vitro adhesivity to the oral mucosa cells of HIV-positive and AIDS patients. I].
    Malighetti V; Arosio M; Bellotti MG; Spadari E; Zambellini Artini M; Spadari F; Riviera L
    Minerva Stomatol; 1998 Sep; 47(9):351-9. PubMed ID: 9835741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of adhesive properties of Candida albicans isolated from the oral cavity in HIV positive patients.
    Macura AB; Bort A
    Wiad Parazytol; 2001; 47(4):723-8. PubMed ID: 16886417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.
    Schulz B; Weber K; Schmidt A; Borg-von Zepelin M; Ruhnke M
    Mycoses; 2011 Sep; 54(5):e522-30. PubMed ID: 21605180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells.
    Sweet SP; Cookson S; Challacombe SJ
    J Med Microbiol; 1995 Dec; 43(6):452-7. PubMed ID: 7473680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans and HIV-1 Infection.
    Pugliese A; Torre D; Baccino FM; Di Perri G; Cantamessa C; Gerbaudo L; Saini A; Vidotto V
    Cell Biochem Funct; 2000 Dec; 18(4):235-41. PubMed ID: 11180285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis].
    Ruhnke M; Tennagen I; Engelmann E
    Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Candida albicans isolates from the oral cavity of HIV-positive patients.
    Woldeamanuel Y; Abate D
    Ethiop Med J; 1998 Oct; 36(4):235-43. PubMed ID: 11957299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro study of oral Candida albicans in virulence from HIV-positive individuals].
    Liu XS; Liu HW; Guo ZJ; Luan WM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 May; 40(3):211-4. PubMed ID: 15938881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence of different Candida dubliniensis isolates in the presence of fluconazole.
    Borg-von Zepelin M; Niederhaus T; Gross U; Seibold M; Monod M; Tintelnot K
    AIDS; 2002 Jun; 16(9):1237-44. PubMed ID: 12045488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence of Staphylococcus aureus, Klebsiella pneumoniae and Candida albicans to human buccal epithelial cells, from healthy persons and HIV carriers, under the influence of Broncho Vaxom in vitro and ascorbic acid in vivo.
    Fortis AA; Lianou PE; Papavassilliou JT
    APMIS; 1998 Apr; 106(4):441-8. PubMed ID: 9637265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Weig M; Müller FM
    Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.